Trials / Completed
CompletedNCT06010121
Comparison of Bioavailability of Liposomal and Traditional Formulation of Vitamin D3
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- AronPharma Sp. z o. o. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to compare the profiles of 25-hydroxyvitamin D serum concentration in healthy adults after 4 weeks of using vitamin D supplementation either in a liposomal or a traditional formulation.
Detailed description
The study will be randomized, cross-over, participants will be randomly assigned to one of the study groups: A) the group receiving vitamin D3 in traditional formulation B) the group receiving vitamin D3 in liposomal formulation. The day before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation, participants will have their blood drawn. Then, after a wash-out period of 2 months, the groups will be switched. Participants will again receive daily supplementation with vitamin D3 for 4 weeks. Blood will be drawn before the start of supplementation (T0), 2 weeks (T1) and 4 weeks (T2) after the start of supplementation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Liposomal Vitamin D | 2000 IU of cholecalciferol in liposomal formulation |
| DIETARY_SUPPLEMENT | Traditional Vitamin D | 2000 IU of cholecalciferol in traditional formulation |
Timeline
- Start date
- 2023-02-17
- Primary completion
- 2023-06-06
- Completion
- 2023-06-06
- First posted
- 2023-08-24
- Last updated
- 2023-08-25
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06010121. Inclusion in this directory is not an endorsement.